Antoaneta Vladimirova
Overview
Explore the profile of Antoaneta Vladimirova including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
202
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pizurica M, Zheng Y, Carrillo-Perez F, Noor H, Yao W, Wohlfart C, et al.
Nat Commun
. 2024 Nov;
15(1):9886.
PMID: 39543087
Cancer is a heterogeneous disease requiring costly genetic profiling for better understanding and management. Recent advances in deep learning have enabled cost-effective predictions of genetic alterations from whole slide images...
2.
Dolatabadi E, Moyano D, Bales M, Spasojevic S, Bhambhoria R, Bhatti J, et al.
J Med Internet Res
. 2023 Dec;
25:e55010.
PMID: 38064711
[This corrects the article DOI: 10.2196/45767.].
3.
Duroux D, Wohlfart C, Van Steen K, Vladimirova A, King M
Sci Rep
. 2023 Nov;
13(1):19653.
PMID: 37949935
Personalised cancer screening before therapy paves the way toward improving diagnostic accuracy and treatment outcomes. Most approaches are limited to a single data type and do not consider interactions between...
4.
Zheng Y, Pizurica M, Carrillo-Perez F, Noor H, Yao W, Wohlfart C, et al.
bioRxiv
. 2023 Oct;
PMID: 37808782
Cancer is a heterogeneous disease that demands precise molecular profiling for better understanding and management. Recently, deep learning has demonstrated potentials for cost-efficient prediction of molecular alterations from histology images....
5.
Dolatabadi E, Moyano D, Bales M, Spasojevic S, Bhambhoria R, Bhatti J, et al.
J Med Internet Res
. 2023 Sep;
25:e45767.
PMID: 37725432
Background: While scientific knowledge of post-COVID-19 condition (PCC) is growing, there remains significant uncertainty in the definition of the disease, its expected clinical course, and its impact on daily functioning....
6.
Paranavitana C, DaSilva L, Vladimirova A, Pittman P, Velauthapillai M, Nikolich M
Pathog Dis
. 2014 Jan;
70(2):141-52.
PMID: 24453125
Global gene expression profile changes were monitored in human peripheral blood mononuclear cells (PBMCs) after challenge with the live vaccine strain (LVS) of Francisella tularensis. Because these PBMCs were from...
7.
Einbond L, Soffritti M, Esposti D, Park T, Cruz E, Su T, et al.
Fundam Clin Pharmacol
. 2009 Jun;
23(3):311-21.
PMID: 19527300
The purpose of this study was to assess in rats the pharmacological parameters and effects on gene expression in the liver of the triterpene glycoside actein. Actein, an active component...
8.
Ganter B, Zidek N, Hewitt P, Muller D, Vladimirova A
Pharmacogenomics
. 2007 Dec;
9(1):35-54.
PMID: 18154447
The pharmaceutical industry has begun to leverage a range of new technologies (proteomics, pharmacogenomics, metabolomics and molecular toxicology [e.g., toxicogenomics]) and analysis tools that are becoming increasingly integrated in the...
9.
Ganter B, Tugendreich S, Pearson C, Ayanoglu E, Baumhueter S, Bostian K, et al.
J Biotechnol
. 2005 Jul;
119(3):219-44.
PMID: 16005536
Successful drug discovery requires accurate decision making in order to advance the best candidates from initial lead identification to final approval. Chemogenomics, the use of genomic tools in pharmacology and...
10.
Nie L, Xu M, Vladimirova A, Sun X
EMBO J
. 2003 Nov;
22(21):5780-92.
PMID: 14592976
Notch signals are important for lymphocyte development but downstream events that follow Notch signaling are not well understood. Here, we report that signaling through Notch modulates the turnover of E2A...